Breaking News Instant updates and real-time market news.

2019-02-13 15:19:33 GS Goldman Sachs $196.47 1.98 (1.02%) 15:19 02/13/19 02/13 15:19 02/13/19 15:19	Goldman execs says cost of 1MDB scandal could be about $10B, FBN says Charles Gasparino of Fox Business Network tweeted: "SCOOP: Senior @GoldmanSachs execs telling people cost of 1MDB scandal could amount to a "year of earnings," or about $10 billion--co sources. The size of the potential liability caused $GS to institute claw-back provision on exec pay-co sources" Reference Link	27 Feb 03 Mar
GS Goldman Sachs $196.47 1.98 (1.02%) 02/01/19 02/01/19 DOWNGRADE Sell Societe Generale downgrades Goldman Sachs, Morgan Stanley to Sell As previously reported, Societe Generale analyst Andrew Lim downgraded Goldman Sachs (GS) and Morgan Stanley (MS), both to Sell from Hold, citing his view that the credit cycle deterioration "has already been set in motion" and that it will pay to be defensive for the rest of 2019. Goldman and Morgan are much more exposed to pressure on market-sensitive revenues as purer investment banks, Lim tells investors. He does not have any Buy ratings on big U.S. banks, but continues to favor holding positions in Bank of America (BAC) and JP Morgan (JPM), which Lim views as the most defensive large cap U.S. banks, he tells investors. 02/01/19 SOCG 02/01/19 DOWNGRADE SOCG Sell Goldman Sachs downgraded to Sell from Hold at Societe Generale Societe Generale analyst Andrew Lim downgraded Goldman Sachs to Sell from Hold. 01/25/19 OPCO 01/25/19 NO CHANGE OPCO Outperform Bank stocks still 'resoundingly cheap,' says Oppenheimer Oppenheimer analyst Chris Kotowski told investors in a research note that one reason he is so "incessantly bullish" on bank stocks is that investors "still so incessantly hate them." The stocks still remain resoundingly cheap at a 63% relative P/E multiple even though bank balance sheets are arguably the best they have ever been, and the business models decidedly less capital-intensive, he contends. He continues to recommend Outperform-rated Bank of America (BAC), CIT (CIT), Citi (C), Goldman (GS), Jefferies (JEF), Morgan Stanley (MS) and U.S. Bancorp (USB). 01/17/19 BMOC 01/17/19 NO CHANGE Target $262 BMOC Market Perform Goldman Sachs price target lowered to $262 from $276 at BMO Capital BMO Capital analyst James Fotheringham lowered his price target on Goldman Sachs to $262 and kept his Market Perform rating after its Q4 results, saying that while it beat on revenues, its non-comp expenses are seen rising. The analyst adds that he is "gratified" by the "value-restoring" rebound in bank stocks after the December rout and anticipates "relatively benign system-wide fundamental credit quality over the next two years." Fotheringham also lowers his FY19 EPS view by 1% to $24.85 to reflect his outlook for higher expenses, stating that other large -cap banks, specialty lenders, and financial technology stocks offer investors a "greater opportunity".

2019-02-13 15:19:33

Goldman Sachs

$196.47: 1.98 (1.02%)

15:19

02/13/19

02/13

15:19

02/13/19

15:19

Goldman execs says cost of 1MDB scandal could be about $10B, FBN says

Charles Gasparino of Fox Business Network tweeted: "SCOOP: Senior @GoldmanSachs execs telling people cost of 1MDB scandal could amount to a "year of earnings," or about $10 billion--co sources. The size of the potential liability caused $GS to institute claw-back provision on exec pay-co sources" Reference Link

27
Feb
03
Mar

GS Goldman Sachs

$196.47: 1.98 (1.02%)

02/01/19

02/01/19: SOCG

01/25/19: OPCO

01/17/19: BMOC

TODAY'S FREE FLY STORIES

ZGNX Zogenix $47.88 0.35 (0.74%) 07:30 02/22/19 02/22 07:30 02/22/19 07:30 Initiation	Zogenix initiated » Zogenix initiated with a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
GE General Electric $10.03 -0.07 (-0.69%) , JNJ Johnson & Johnson $135.40 -0.91 (-0.67%) … 07:30 02/22/19 02/22 07:30 02/22/19 07:30 Options	Unusual put flow in option market yesterday » Notable put activity was… GE General Electric $10.03 -0.07 (-0.69%) JNJ Johnson & Johnson $135.40 -0.91 (-0.67%) M Macy's $24.44 -0.58 (-2.32%) CZR Caesars $9.42 -0.21 (-2.18%) KEM Kemet $18.87 -0.56 (-2.88%) COUP Coupa Software $92.20 -1.55 (-1.65%) SM SM Energy $17.01 -2.69 (-13.65%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 25 Feb 26 Feb 27 Feb 03 Mar 06 Mar 11 Mar 12 Mar 12 Mar
ROKU Roku $51.47 -2.16 (-4.03%) 07:29 02/22/19 02/22 07:29 02/22/19 07:29 Recommendations	Roku analyst commentary » Roku price target raised… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SM SM Energy $17.01 -2.69 (-13.65%) 07:29 02/22/19 02/22 07:29 02/22/19 07:29 Recommendations	SM Energy analyst commentary » SM Energy price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
MRK Merck $79.82 0.38 (0.48%) 07:28 02/22/19 02/22 07:28 02/22/19 07:28 Initiation	Merck initiated » Merck initiated with an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	11 Apr 18 May 17 Jun

SAGE Sage Therapeutics $146.14 -1.32 (-0.90%) 07:28 02/22/19 02/22 07:28 02/22/19 07:28 Initiation	Sage Therapeutics initiated » Sage Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 19 Mar
BMRN BioMarin $88.80 -1.82 (-2.01%) 07:26 02/22/19 02/22 07:26 02/22/19 07:26 Recommendations	BioMarin analyst commentary » BioMarin base business… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
RARX RA Pharmaceuticals $19.59 1 (5.38%) 07:26 02/22/19 02/22 07:26 02/22/19 07:26 Initiation	RA Pharmaceuticals initiated » RA Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
TSM TSMC $38.98 -0.03 (-0.08%) 07:26 02/22/19 02/22 07:26 02/22/19 07:26 Periodicals	TSMC getting traction for AI, 5G 'boom' with its EUV process, DigiTimes says » The upcoming Mobile World… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
TER Teradyne $41.10 -0.05 (-0.12%) 07:26 02/22/19 02/22 07:26 02/22/19 07:26 Downgrade	Teradyne rating change » Teradyne downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	10 Apr 28 May

INTU Intuit $234.85 -1.06 (-0.45%) 07:25 02/22/19 02/22 07:25 02/22/19 07:25 Recommendations	Intuit analyst commentary » Intuit price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb
AAOI Applied Optoelectronics 07:25 02/22/19 02/22 07:25 02/22/19 07:25 Downgrade	Applied Optoelectronics rating change » Applied Optoelectronics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Feb 27 Feb 28 Feb
ANIK Anika Therapeutics $40.45 0.45 (1.13%) 07:24 02/22/19 02/22 07:24 02/22/19 07:24 Downgrade	Anika Therapeutics rating change » Anika Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
LOPE Grand Canyon $118.12 20.99 (21.61%) 07:24 02/22/19 02/22 07:24 02/22/19 07:24 Recommendations	Grand Canyon analyst commentary » Grand Canyon price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
DIN Dine Brands $99.45 10.93 (12.35%) 07:23 02/22/19 02/22 07:23 02/22/19 07:23 Recommendations	Dine Brands analyst commentary » Dine Brands price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

IFRX InflaRx $31.65 -0.83 (-2.56%) 07:23 02/22/19 02/22 07:23 02/22/19 07:23 Initiation	InflaRx initiated » InflaRx initiated with a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
LNVGY Lenovo $0.00 (0.00%) 07:22 02/22/19 02/22 07:22 02/22/19 07:22 Upgrade	Lenovo rating change » Lenovo upgraded to Buy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb
GWPH GW Pharmaceuticals $143.86 -2.16 (-1.48%) 07:21 02/22/19 02/22 07:21 02/22/19 07:21 Initiation	GW Pharmaceuticals initiated » GW Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Feb
ROKU Roku $51.47 -2.16 (-4.03%) 07:21 02/22/19 02/22 07:21 02/22/19 07:21 Downgrade	Roku rating change » Roku downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
NAVI Navient $12.33 -0.32 (-2.53%) 07:20 02/22/19 02/22 07:20 02/22/19 07:20 Hot Stocks	Navient issues statement regarding Canyon nomination of four directors for board » Navient issued the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

XNCR Xencor $32.22 -1.54 (-4.56%) 07:20 02/22/19 02/22 07:20 02/22/19 07:20 Downgrade	Xencor rating change » Xencor downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 27 Feb
GBT Global Blood Therapeutics $50.04 -0.45 (-0.89%) 07:19 02/22/19 02/22 07:19 02/22/19 07:19 Initiation	Global Blood Therapeutics initiated » Global Blood Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb
FIT Fitbit $6.62 -0.03 (-0.45%) 07:18 02/22/19 02/22 07:18 02/22/19 07:18 Downgrade	Fitbit rating change » Fitbit downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 27 Feb
STMP Stamps.com , FDX FedEx $182.28 0.52 (0.29%) … 07:18 02/22/19 02/22 07:18 02/22/19 07:18 Recommendations	Stamps.com, FedEx, UPS, Amazon.com analyst commentary » Stamps.com should return… STMP Stamps.com FDX FedEx $182.28 0.52 (0.29%) UPS UPS $111.76 0.68 (0.61%) AMZN Amazon.com $1,619.84 -2.26 (-0.14%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	03 Mar 18 Mar 19 Mar 01 Apr 02 Apr
ARGX Argenx $122.20 -2.84 (-2.27%) 07:18 02/22/19 02/22 07:18 02/22/19 07:18 Initiation	Argenx initiated » Argenx initiated with a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

Events

Earnings calls, analyst events, roadshows and more

BXG
Today at 08:00

Bluegreen Vacations - BXG Conference Calls
KL
Today at 08:00

Kirkland Lake Gold - KL Conference Calls
GLPG
Today at 08:00

Galapagos NV - GLPG Conference Calls
JRVR
Today at 08:00

James River Group - JRVR Conference Calls
W
Today at 08:00

Wayfair - W Conference Calls
ELGX
Today at 08:00

Endologix Inc. Firm Sponsored Meetings

2 Musick, Irvine, CA
SWM
Today at 08:30

Schweitzer-Mauduit - SWM Conference Calls
HMSY
Today at 08:30

HMS Holdings - HMSY Conference Calls
INSM
Today at 08:30

Insmed - INSM Conference Calls
RUTH
Today at 08:30

Ruth's Hospitality - RUTH Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	AI X AI Arlington Asset Investment Spot Secondary Managers: Morgan Stanley & JMP Securities Priced at: $8.33 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ARR X ARR ARMOUR Residential Spot Secondary Managers: Morgan Stanley & Barclays, Citi, Credit Suisse, Goldman Sachs & JPMorgan Priced at: $20.33 7.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CPT X CPT Camden Property Spot Secondary Managers: BofA/Merrill & Deutsche Bank Priced at: $97.85 3.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NRZ X NRZ New Residential Spot Secondary Managers: Morgan Stanley, Credit Suisse & JPMorgan Priced at: $16.50 40.3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OVID X OVID Ovid Therapeutics Spot Secondary Managers: Cowen & William Blair Priced at: $2.00 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SNNA X SNNA Sienna Biopharmaceuticals Spot Secondary Managers: Cowen & BMO Capital Priced at: $2.50 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	RWLK X RWLK ReWalk Robotics Spot Secondary Managers: H.C. Wainwright Priced at: $.23 19M Shares
Thurs	ACAM X ACAM Acamar Partners IPO Managers: Goldman Sachs & Deutsche Bank Priced at: $10.00 30M Shares
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	TRIL X TRIL Trillium Therapeutics Spot Secondary Managers: Cowen $1.28 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Goldman execs says cost of 1MDB scandal could be about $10B, FBN says

TODAY'S FREE FLY STORIES

Get Full Fly Access